GAAD Score as a Prognostic Model for Recurrence of Hepatocellular Carcinoma After Curative Resection
The Kaohsiung Journal of Medical Sciences · 14.11.2026
DOI: 10.1002/kjm2.70318 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Kaohsiung Journal of Medical Sciences, online erschienen am 14.11.2026. Verfasst von Yueh-Jen Chung und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hepato-Gastroenterology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Chang Gung Memorial Hospital.
Abstract (Originalsprache)
Hepatocellular carcinoma (HCC) has a high recurrence rate after curative resection. The GAAD score, which combines gender, age, α‐fetoprotein (AFP), and PIVKA‐II, was developed for HCC detection, but its prognostic value after resection remains unclear. We retrospectively analyzed 294 patients who underwent curative‐intent liver resection for HCC at a single center. The prognostic associations of preoperative GAAD, AFP, and PIVKA‐II with recurrence‐free survival (RFS) and overall survival (OS) were evaluated using Kaplan–Meier analysis and Cox regression. During a median follow‐up of 86.8 months (IQR, 26.6–112.3), 168 patients (57.1%) developed recurrence and 114 (38.8%) died. GAAD ≥ 1 was associated with shorter RFS ( p = 0.005) and remained independently associated with recurrence after adjustment for clinicopathological factors (HR 1.85, 95% CI 1.09–3.15; p = 0.023). This association remained significant in patients with BCLC stage 0/A. Among patients with AFP < 7 ng/mL, GAAD ≥ 1 remained independently associated with recurrence, whereas PIVKA‐II ≥ 22 ng/mL did not. GAAD ≥ 1 was not associated with OS. In conclusion, GAAD ≥ 1 was independently associated with postoperative HCC recurrence but not with OS. Given its modest discrimination and cohort‐derived cutoff, these exploratory findings require external validation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Hepato-Gastroenterology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan.
- Kaohsiung Municipal Feng Shan Hospital - Under the Management of Chang Gung Medical Foundation, Kaohsiung, Taiwan.
- Division of Hematology Oncology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan.
- Division of General Surgery, Department of Surgery, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan.
- School of Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.
ORCID-Profile: Yueh-Jen Chung, Chia-Che Wu, Yuan-Hung Kuo, Chao-Hung Hung, Ming-Chao Tsai
Förderung
- Chang Gung Memorial Hospital
Zitieren
APA
Chung, Y. J., Wu, C. C., Li, W. F., Liu, Y. W., Wang, H. M., Kuo, Y. H., Hung, C. H., Tsai, M. J., & Tsai, M. C. (2026). GAAD Score as a Prognostic Model for Recurrence of Hepatocellular Carcinoma After Curative Resection. The Kaohsiung Journal of Medical Sciences. https://doi.org/10.1002/kjm2.70318
Vancouver
Chung YJ, Wu CC, Li WF, Liu YW, Wang HM, Kuo YH, et al. GAAD Score as a Prognostic Model for Recurrence of Hepatocellular Carcinoma After Curative Resection. The Kaohsiung Journal of Medical Sciences. 2026. doi:10.1002/kjm2.70318
BibTeX
@article{Chung2026,
author = {Chung, Yueh-Jen and Wu, Chia-Che and Li, Wei-Feng and Liu, Yueh-Wei and Wang, Hsin-Ming and Kuo, Yuan-Hung and Hung, Chao-Hung and Tsai, Mu-Jung and Tsai, Ming-Chao},
title = {GAAD Score as a Prognostic Model for Recurrence of Hepatocellular Carcinoma After Curative Resection},
journal = {The Kaohsiung Journal of Medical Sciences},
year = {2026},
doi = {10.1002/kjm2.70318}
}
EUVIMED